BLUSF (MC $20 M) (Cash $16M ) Big Rare Disease Drug in Phase 3 Close to End = 1000% !

[Biotechmaster]

Just look at Volume and you will know that almost nobody knows this Monster Sleeping Giant with brutally upside potential means you have the opportunity to buy at the Bottom and before it hit the radar of investors !!!!

Here is Why i like the Company so much :

1) Trading at Cash Level
2) Very Low Burn-Rate of $900k per Q (Cash untill Late 2017)
3) Strong Insider and Institutional Ownership (Holding 70% of the 47.3 M Share Outstanding )
4) KIACTA